APG Asset Management N.V. Cuts Stock Position in STERIS plc $STE

APG Asset Management N.V. decreased its holdings in shares of STERIS plc (NYSE:STE) by 9.3% during the third quarter, HoldingsChannel reports. The institutional investor owned 1,428,053 shares of the medical equipment provider’s stock after selling 145,679 shares during the period. STERIS accounts for about 0.6% of APG Asset Management N.V.’s holdings, making the stock its 21st biggest holding. APG Asset Management N.V.’s holdings in STERIS were worth $353,357,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Steigerwald Gordon & Koch Inc. acquired a new position in STERIS during the third quarter worth $25,000. Cloud Capital Management LLC acquired a new position in shares of STERIS during the 3rd quarter worth about $29,000. Spurstone Advisory Services LLC purchased a new position in STERIS in the 2nd quarter valued at about $29,000. Geneos Wealth Management Inc. lifted its stake in STERIS by 416.0% in the 1st quarter. Geneos Wealth Management Inc. now owns 129 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 104 shares in the last quarter. Finally, TruNorth Capital Management LLC acquired a new stake in STERIS in the 3rd quarter worth about $37,000. Institutional investors and hedge funds own 94.69% of the company’s stock.

STERIS Stock Down 0.9%

NYSE STE opened at $252.36 on Friday. STERIS plc has a 52 week low of $204.90 and a 52 week high of $269.44. The company has a quick ratio of 1.75, a current ratio of 2.48 and a debt-to-equity ratio of 0.26. The business’s fifty day simple moving average is $255.83 and its 200-day simple moving average is $251.73. The firm has a market cap of $24.75 billion, a PE ratio of 35.20 and a beta of 1.03.

STERIS (NYSE:STE) last announced its quarterly earnings data on Wednesday, February 4th. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $2.53. STERIS had a net margin of 12.15% and a return on equity of 14.34%. During the same period last year, the company earned $2.32 earnings per share. STERIS’s revenue was up 9.2% on a year-over-year basis. STERIS has set its FY 2026 guidance at 10.150-10.300 EPS. As a group, equities analysts anticipate that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Stockholders of record on Tuesday, February 17th will be issued a dividend of $0.63 per share. The ex-dividend date is Tuesday, February 17th. This represents a $2.52 dividend on an annualized basis and a dividend yield of 1.0%. STERIS’s dividend payout ratio (DPR) is currently 35.15%.

Analysts Set New Price Targets

A number of equities analysts have commented on the company. Weiss Ratings reissued a “buy (b)” rating on shares of STERIS in a report on Friday, January 9th. Wall Street Zen cut STERIS from a “strong-buy” rating to a “buy” rating in a research report on Saturday, February 14th. Six research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $275.20.

About STERIS

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.